Results 111 to 120 of about 2,590,210 (272)

Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review

, 2022
Idevaldo Floriano, Antônio Silvinato, João Conrado Bueno dos Reis, Claudia Cafalli, Wanderley Marques Bernardo   +4 more
openalex   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer

Cancers, 2019
The management of peritoneal metastases from gastric cancer origin has evolved considerably over the last three decades with the establishment of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as efficacious therapies ...
Adriana C. Gamboa, J. Winer
semanticscholar   +1 more source

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations

Current Oncology
Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different ...
Miklos Acs, Pompiliu Piso, Gabriel Glockzin   +2 more
doaj   +1 more source

Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei

Annals of Thoracic Surgery Short Reports
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Luke J. Matzek, MD, Jaelin J. Otta, MD, Ryan E. Hofer, MD, Charles R. Sims, 3rd, MD, Mitchell J. Kerfeld, MD, Thomas M. Stewart, MD, Travis E. Grotz, MD, Luis F. Tapias, MD   +7 more
doaj   +1 more source

Cytoreductive surgery for men with metastatic prostate cancer

Prostate International, 2016
Background: Cytoreductive surgery for metastatic prostate cancer is an emerging area of interest with a potential upside that includes local control, delayed initiation of hormone therapy, and possibly improved cancer specific survival.
Nikolas Katelaris, Declan Murphy, Nathan Lawrentschuk, Athos Katelaris, Daniel Moon   +4 more
doaj   +1 more source

Nephrotoxic synergism of cisplatin and mitomycin-C for hyperthermic intraperitoneal chemotherapy and cytoreductive surgery [PDF]

, 2018
Ravish Kapoor, Kristen A. Robinson, Brian D. Badgwell   +2 more
openalex   +1 more source

Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?

BMC Women's Health
Background This study aimed to determine the effect of neoadjuvant chemotherapy (NACT) on the complex surgical procedures required in addition to staging surgery for the need to achieve a residual tumor 1 cm or less in a population of stage IIIC–IV ...
Okan Aytekin, Simge Kirmizigul Kerinc, Abdurrahman Alp Tokalioglu, Yesim Ozkaya Ucar, Fatih Kilic, Gunsu Kimyon Comert, Gokhan Ucar, Burak Civelek, Taner Turan   +8 more
doaj   +1 more source

Malignant Mixed Mullerian tumors of the ovary: The result of Platinum-based combination chemotherapy following the cytoreductive surgery [PDF]

, 2005
Jin Young, Yong‐Man Kim, Min Hyung Jung, Sang Min Park, Dae Yeon Kim, Jong Hyeok Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok   +8 more
openalex   +1 more source

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details [PDF]

, 2021
Thomas Boerner, Pompiliu Piso
openalex   +1 more source

Long‐term survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Waikato, Aotearoa New Zealand: a 12‐year experience [PDF]

, 2023
Rennie Xinrui Qin, Jia Hui Lim, Jasen Ly, Jesse Fischer, Nicholas Smith, Mosese Karalus, Linus Wu, R. van Dalen, Simione Lolohea   +8 more
openalex   +1 more source